Search

everythinglearnresearchcommunity

for

Search:↓

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

Certain hair and scalp features indicate a worse outcome in alopecia areata.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

A new classification and scoring system is needed for alopecia areata to better assess severity.

Scoring systems help doctors assess and treat skin diseases effectively.

Current tools inadequately measure quality of life in children with alopecia areata, needing better instruments.

WAA-QOL measures impact of hair loss on women's well-being.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.

The instruments are valid but don't fully capture the emotional impact on adolescents with alopecia areata.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Children with alopecia areata in Singapore generally have a good quality of life.

Hair loss may indicate higher risk of heart disease.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Men often see themselves as balder than experts do.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

The protocol is easy to use, but reliable results need the same person to assess each time.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

Alopecia areata severity is influenced by hair loss, emotional, and financial burdens.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.